Patent directory · USPTO A61K / A61P
Patents matching “modified”
433 pharma patents match "modified" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 433 pharmaceutical patents matching "modified" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11427822
Modified double-stranded RNA agents
granted -
US 11419318
Genetically modified rat comprising a humanized TRKB locus
granted -
US 11414657
Modified CRISPR RNA and modified single CRISPR RNA and uses thereof
granted -
US 11406716
Modified RNAi agents
granted -
US 11401513
Modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use
granted -
US 11401517
Modified double-stranded RNA agents
granted -
US 11384335
Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)
granted -
US 11377646
Modified cells comprising CRISPR systems
granted -
US 11377659
Short hairpin RNA (shRNA734) and use of same to positively select and eliminate genetically modified cells
granted -
US 11351120
Use of higher doses of modified release huperzine formulations
granted -
US 11345928
Modified immunization vectors
granted -
US 11344577
Car+ T cells genetically modified to eliminate expression of T-cell receptor and/or HLA
granted -
US 11344569
Treatment of sleep-wake disorders and neurodegenerative disease comprising modified resistant maltodextrin
granted -
US 11339387
Modified foot-and-mouth disease virus 3C proteases and methods for processing FMDV P1 precursor polypeptide
granted -
US 11326156
Modified caspase-9 polypeptides and methods of use thereof
granted -
US 11312957
Modified iRNA agents
granted -
US 11299482
Salt and crystal form of modified andrographolide compound and preparation method thereof
granted -
US 11293010
Methods of producing modified natural killer cells and methods of use
granted -
US 11286291
Co-stimulatory domains for use in genetically-modified cells
granted -
US 11266724
Modified factor VII polypeptides for subcutaneous administration and on-demand treatment
granted -
US 11268065
Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
granted -
US 11261237
Modified pigment epithelium-derived factor (PEDF) peptides and uses thereof for treating neovascular diseases, inflammatory diseases, cancer, and for cytoprotection
granted -
US 11246930
Reoviruses having modified sequences
granted -
US 11234418
Genetically modified cells, tissues, and organs for treating disease
granted